Intercept Pharmaceuticals interceptpharma.com


Public list: Pharma Startups (6570) Rare Diseases (230)

Intercept Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat chronic liver disease utilizing expertise in bile acid chemistry. The company's product candidates have the potential to treat orphan and more prevalent liver diseases for which there currently are limited therapeutic solutions.

Intercept Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat chronic liver disease utilizing expertise in bile acid chemistry. The company's product candidates have the potential t...Show all

Company (IPO / Went public)

Phone: 646-747-1000

Fax:

18 Desbrosses Street

New York, 10013
New York, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Intercept Pharmaceuticals $121M Apr 5, 2018
See all 42 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Intercept Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 42 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Preparation and uses of obeticholic acid Dec 22, 2015 May 29, 2018 Patent
Process for preparing bile acid derivatives Oct 25, 2013 Oct 03, 2017 Patent
Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated diseases or conditions Jun 18, 2015 Sep 19, 2017 Patent
Steroids as agonists for fxr Feb 05, 2016 Aug 15, 2017 Patent
Preparation and uses of obeticholic acid Nov 20, 2015 Aug 15, 2017 Patent
See all 23 patents